ArticleArthritis research & therapy2011

A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis.

Kristine L Stump et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.